Special Issue "Noncoding RNAs as New Instruments in the Orchestration of Cell Death and Cancer Therapy Resistance 2.0"
Deadline for manuscript submissions: 15 December 2021.
Interests: cell death mechanisms; microRNAs; long non coding RNAs; biomarkers; nanotechnology; drug delivery; signal transduction; target therapy; cancer; circulating tumor cells; glioblastoma; prostate cancer; hepatocellular cancer
Interests: microRNAs; long non-coding RNAs; extracellular vesicles; regulation of gene expression; cell death mechanisms; cell signaling; cancer therapy; drug delivery systems; target therapy; immunotherapy; prostate cancer; colorectal cancer; glioblastoma
Special Issues and Collections in MDPI journals
Special Issue in Journal of Clinical Medicine: Novel Biomarkers and Therapeutic Targets for Human Cancers
Special Issue in International Journal of Molecular Sciences: Sirtuins and Epigenetics in Aging and Diseases 2.0
Special Issue in International Journal of Molecular Sciences: Apoptosis and Autophagy: The Double Edge in Cancer Development and Progression and in Other Human Diseases 3.0
Noncoding RNAs (ncRNAs) are emerging as key orchestrators of tumorigenesis. Recent advances in biotechnologies, such as high-throughput sequencing, genome editing, and mouse modeling, have allowed for functional studies of ncRNAs to provide new perspectives in the fight against cancer. In addition to miRNAs and lncRNAs, that play a key role in the regulation of gene expression, other novel ncRNAs, such as transfer RNA (tRNA) fragments, snoRNA-related lncRNAs (sno-lncRNAs), and circRNAs have also appeared on the radar of cancer researchers. Increasing evidence shows that ncRNAs function either as tumor suppressors or oncogenes by regulating one or several cancer hallmarks, including evading cell death, metastasis, and drug resistance. Cancer therapy resistance is a major challenge in clinics and scientific research, resulting in tumor recurrence and metastasis. The mechanisms of therapy resistance are complex and result from multiple factors. Among them, ncRNAs have been shown to regulate drug resistance by targeting drug resistance-related genes or influencing genes related to cell proliferation and cell death. Indeed, ncRNAs target and inhibit the expression of several cellular regulators, including those controlling programmed cell death via the intrinsic and extrinsic, p53-, and endoplasmic reticulum (ER) stress-induced apoptotic pathways, as well as pathways of necroptosis, mitophagy, and autophagy.
This Special issue will focus on the recent advances in “Noncoding RNAs as New Instruments in the Orchestration of Cell Death and Cancer Therapy Resistance”, including new findings concerning ncRNAs that modulate apoptosis, autophagy, and other programmed cell death and cancer resistance pathways, as well as emerging data on miRNA–lncRNA interactions that affect cell death regulation and mechanisms of resistance to therapy. Current research progress on ncRNAs for clinical and/or potential translational applications, including the identification of novel therapeutic approaches for ncRNA targeting and delivery strategies, will be also appreciated.
Dr. Silvia Zappavigna
Dr. Amalia Luce
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- regulatory ncRNAs
- cell death mechanisms
- cancer therapy
- cancer resistance
- ncRNA based-therapy
- ncRNA deregulation
- delivery strategies
- miRNA/lncRNA interactions